Location History:
- Brookline, MA (US) (2016 - 2019)
- Watertown, MA (US) (2018 - 2024)
Company Filing History:
5 out of 35 
3 out of 4 
1 out of 34 
Years Active: 2016-2024
Title: Mathew Edward Sowa: Innovator in Pharmaceutical Compounds
Introduction
Mathew Edward Sowa, an accomplished inventor based in Watertown, MA, has contributed significantly to the field of pharmaceuticals with nine patents to his name. His work focuses on innovative compounds capable of modulating biological processes that have the potential to advance therapeutic solutions.
Latest Patents
Among his latest innovations, Sowa has developed compounds that participate in cooperative binding and their respective applications. This invention features macrocyclic compounds designed to bind to presenter proteins such as members of the FKBP family and cyclophilin family, selectively modulating the activity of target proteins like CEP250. The creation of tripartite complexes, involving presenter proteins, compounds, and target proteins, underscores the intricate interplay of both protein-compound and protein-protein interactions essential for effective modulation of biological activity. Additionally, Sowa has disclosed methods aimed at identifying novel drug candidates, enhancing the search for new therapeutic agents in medical science.
Career Highlights
Mathew Edward Sowa has made a mark through his tenure at reputable companies such as Revolution Medicines, Inc. and Warp Drive Bio, Inc. His innovative contributions at these organizations reflect a commitment to advancing drug development and pharmaceutical research.
Collaborations
Throughout his career, Sowa has collaborated with notable professionals including Gregory Lawrence Verdine and Brian Roger Bowman. These partnerships have further enriched the landscape of research and development in which he actively participates.
Conclusion
Mathew Edward Sowa’s journey as an inventor exemplifies a dedication to pushing the boundaries of innovation in pharmaceuticals. His patents signify not only advancements in drug development but also the collaborative spirit that propels scientific discoveries forward. With a focus on cooperative binding and novel therapeutic agents, Sowa continues to impact the field significantly.